Visit other SMART + STRONG sites:
AIDSMEDSREAL HEALTHTU SALUD
Subscribe to:
POZ magazine
E-newsletters
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Treatment News


November 30, 2006
Not So SMART: Interruption Strategy Questioned
Results from one of the largest HIV clinical trials ever conducted conclude that a specific strategy of interrupting HIV treatment more than doubles the risk of disease progression or death and is actually associated with a higher risk of serious side effects.
COPD More Likely in Patients With HIV
In keeping with findings in the pre-HAART era, it appears that chronic obstructive pulmonary disease (COPD) continues to be more common in patients who are HIV-positive compared to those who are HIV negative, researchers report in the November issue of Chest.
Thymidine-Sparing Regimen Improves Lipoatrophy
Switching from a thymidine nucleoside analogue to tenofovir or abacavir can improve the loss of limb fat mass in HIV-infected patients with lipoatrophy, according to a report in the October 24th issue of AIDS.
November 29, 2006
Psychiatric Disorders Make HIV Treatment Costly
Neuropsychiatric disorders (NPD) add substantially to the cost of treatment of HIV-infected patients, according to a report in the October 24th issue of AIDS.
Micronutrient Deficiency Rare in Treated Patients
Low micronutrient levels were uncommon in a study of HIV-positive people receiving antiretroviral therapy, according to a report published in the December 1 issue of the Journal of Acquired Immune Deficiency Syndromes.
World AIDS Day Report: "Millions of Lives at Risk"
The International Treatment Preparedness Coalition (ITPC), a group of 800 treatment activists from more than 125 countries, has released a new report evaluating global efforts to increase access to antiretroviral treatment in low- and middle-income countries where it is desperately needed. 
November 27, 2006
Adding Enfuvirtide Doesn't Help
Treatment Adherence Depends on Many Factors
How well people adhere to treatment—take their medications exactly as prescribed— depends on a variety of factors, either positive or negative, many of which are common to HIV-positive people around the world.
Gorilla Virus Source of Some HIV Infections
An article in the November 9 issue of Nature reports the discovery of gorillas living in the wild in Central Africa infected with an HIV-related virus. 
November 21, 2006
Belly Fat Gains no More Common in HIV
Increases in waist size are no more common in HIV-positive men compared to HIV-negative men, according to new data from the Multicenter AIDS Cohort Study (MACS).
Imiquimod for Anal Intraepithelial Neoplasia?
Clinicians in Germany report that treatment with imiquimod usually clears human papillomavirus (HPV)-related anal intraepithelial neoplasia (AIN), without having to resort to surgical or ablative treatments, in HIV-positive men.
HIV Infection On The Rise Worldwide
HIV infection is rising in every region of the world and, most worrying, in countries like Uganda and Thailand that had been heralded as success stories in the fight against AIDS, UNAIDS and the World Health Organisation announced Tuesday.
November 17, 2006
Innate Factors May Block HIV in Women
Upregulation of certain immunologic factors could account for the continued seronegativity of African commercial sex workers at high risk of HIV infection, according to researchers.
November 15, 2006
Boosted Invirase vs. Kaletra
Early results from a 48-week clinical trial comparing Norvir® (ritonavir)-boosted Invirase® (saquinavir) to Kaletra® (lopinavir plus ritonavir) suggests that the protease inhibitors are potentially equal in terms of viral load reductions. 
Vaginal Infections Decline
Over time, there has been a decrease in rates of certain vaginal infections in women with HIV infection, according to researchers.
November 13, 2006
Radiolabeled Antibodies Kill HIV-1-Infected Cells
Radiolabeling antibodies to HIV proteins may provide a successful strategy against the infection, investigators in Germany and the US report in the November issue of PLoS Medicine.
November 10, 2006
Treatment Interruption No Benefit to Multidrug Resistant
No advantages in structured treatment interruption (STI) are seen in patients with multi-drug-resistant HIV, according to final results of a study of the CPCRA 064 study.
November 09, 2006
Success With Radioactive Antibody Therapy
Using a new strategy featuring radioactive antibodies, researchers at the Albert Einstein College of Medicine of Yeshiva University in Bronx, New York, have successfully targeted and destroyed HIV-infected CD4 cells in laboratory experiments involving mice.
Zinc Supplements Don't Improve Diarrhea
Two weeks of treatment with 50 mg zinc twice daily does not reduce or eliminate persistent diarrhea in adults infected with HIV, according to a report by an international team of researchers.
November 08, 2006
Making Babies the Old-Fashioned Way
A new report suggests that natural conception may be a safe option for heterosexual couples in which one partner is HIV positive and the other is HIV negative.
November 07, 2006
Making (Anti)sense of Gene Therapy
Researchers at the University of Pennsylvania School of Medicine have reported encouraging results from a small clinical trial of a gene therapy approach to treat HIV.
Indian Alert on Faulty HIV Tests
Faulty blood-testing kits for HIV and hepatitis may have been fraudulently sold to government clinics across India, possibly resulting in people receiving transfusions of infected blood, officials said on Thursday.
Monoclonal Gammopathy in People With HIV
Monoclonal gammopathy occurs at a younger age and is more often associated with other viral infections in HIV-positive patients than in the general population, investigators in a multicenter report.
Gene Therapy for HIV Infection Shows Promise
Gene therapy with an HIV-based lentiviral vector can decrease viral loads and increase CD4 T cell counts in chronically infected patients who have failed to respond to at least two antiretroviral regimens, results from a phase I study suggest.
November 03, 2006
HIV Treatment: That'll be $618,900, Please
"The Lifetime Cost of Current HIV Care in the United States," a major study appearing in the November 2006 issue of Medical Care, projects that the average lifetime cost of HIV treatment is $618,900.
Once-daily lopinavir/ritonavir effective in HIV
In anti-HIV combination therapy, use of a once-daily lopinavir/ritonavir formulation (Kaletra, Abbott) appears as effective as twice-daily dosing, and may help improve adherence, according to researchers.
November 02, 2006
New U.S. HIV Cases Cost $12 Billion a Year
Future treatment for the 40,000 people infected with HIV in the United States every year will cost $12.1 billion annually, a new study showed on Wednesday.
November 01, 2006
HIV Infects Epithelial And Brain Cells Lacking CD4
HIV is able to infect cells in the female reproductive tract, brain, and colon that lack CD4 receptors, according to a report in the October 1st Journal of Acquired Immune Deficiency Syndromes.
Web Exclusives

Run This Town

A Voice Against HIV, Malaria and TB

Therapeutic Vaccines: Steady Wins the Race

» More

Most Popular Lessons

The HIV Life Cycle

Shingles

Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV

10 Years Ago In POZ


More Treatment News

Have news about HIV? Send press releases, news tips and other announcements to news@poz.com.

November 2009
October 2009
September 2009
August 2009
July 2009
June 2009
May 2009
April 2009
March 2009
February 2009
January 2009
December 2008
November 2008
October 2008
September 2008
August 2008
July 2008
June 2008
May 2008
April 2008
March 2008
February 2008
January 2008
December 2007
November 2007
October 2007
September 2007
August 2007
July 2007
June 2007
May 2007
April 2007
March 2007
February 2007
January 2007
December 2006
November 2006
October 2006
September 2006
August 2006
July 2006
June 2006
May 2006
April 2006
February 2006
Quick Links
Current Issue

HIV 101
HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
Disclosing Your Status
POZ TV
Read the Blogs
Visit the Forums
Women
African American
Latino
Community
Advocacy
Job Listings
Events Calendar
Starting Treatment
My Cool Tools


    behavedave
    San Diego
    California


    scorpiosrock
    Jacksonville
    Florida


    speedy143
    queens
    New York


    fun4charlie2
    Orlando
    Florida
Click here to join POZ Personals!
Talk to Us
Poll
Question: Do young people see the HIV/AIDS epidemic as a serious threat?
Yes
No

Survey
It's A Girl Thing

more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2009 Smart + Strong. All Rights Reserved. Terms of use and Your privacy